Knockdown of TRPC6 expression inhibits glioma growth, invasion, and angiogenesis, and is an important mediator of glioblastoma tumor growth in vitro and in vivo (Chigurupati et al., 2010). Here, TRPC6 is linked to central nervous system cancer.